Table 2.
Dose Interval | N = 101 | Combined Treatment | N = 101 |
---|---|---|---|
2 weeks | 50 (49.50%) | Cyclosporine | 9 (8.91%) |
3 weeks | 5 (4.95%) | Methotrexate | 7 (6.93%) |
4 weeks | 29 (28.71%) | Systemic steroid | 5 (4.95%) |
Increase of interval | 16 (15.84%) | None (dupilumab-only) | 80 (79.21%) |
Decrease of interval | 1 (0.99%) |